It's a good time to be a shareholder in Cambridge Cognition Holdings (LON:COG): as the share approaches its 52-week high, holders may be wondering whether to sell and take the profit, or buy more and ride the uptrend. Shares in Cambrid...
COG — Cambridge Cognition Holdings Share Price
- £36.62m
- £29.83m
- £10.09m
- 69
- 19
- 58
- 43
Momentum
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 60.74 | ||
PEG Ratio (f) | 3.49 | ||
EPS Growth (f) | 21.06% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 57.95 | ||
Price to Tang. Book | 141.41 | ||
Price to Free Cashflow | 9.42 | ||
Price to Sales | 3.63 | ||
EV to EBITDA | 72.23 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 41.77% | ||
Return on Equity | 130.62% | ||
Operating Margin | 2.62% |
Financial Summary
Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | £m | 6.73 | 6.13 | 5.04 | 6.74 | 10.09 | 11.47 | 12.42 | 7.98% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | +25.28 | +17.27 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Latest News & Insights for COG
The Cambridge Cognition Holdings (LON:COG) share price has risen by 10.3% over the past month and it’s currently trading at 53.5. For investors considering whether to buy, hold or sell the stock, the question now is whether this price...
In this article we will quickly re-cap the broker forecasts for Cambridge Cognition Holdings (LON:COG). The Cambridge Cognition Holdings share price has risen by 17.8% over the past month and it’s currently trading at 43.5. For investo...
The Cambridge Cognition Holdings (LON:COG) share price has risen by 24.2% over the past month and it’s currently trading at 39. For investors considering whether to buy, hold or sell the stock, the question now is whether this price ru...
The Cambridge Cognition Holdings (LON:COG) share price has risen by 31.5% over the past month and it’s currently trading at 36. For investors considering whether to buy, hold or sell the stock, the question now is whether this price ru...
Profile Summary
Cambridge Cognition Holdings plc is a neuroscience technology company. The Company develops and markets digital solutions to assess brain health for sale worldwide, principally in the United Kingdom, the United States and Europe. Its products include CANTAB Recruit, CANTAB Connect, Cognition Kit, Cognition eCOA, CANTAB Connect Research, CANTAB Mobile, CANTAB BrainHealth, CANTAB Insight and NeuroVocalix. Its services include neuroscience consultancy, study design, data analysis, study management, data management plan, reporting and interpretation and technical consultancy. Its CANTAB Connect offers digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas. Its Cognition Kit is a custom-designed digital health platform delivering wearable and smartphone applications for high frequency data collection to demonstrate treatment efficacy and increase the understanding of a disease and a patient's response to medication.
Directors
- Last Annual
- December 31st, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- September 12th, 2012
- Public Since
- April 18th, 2013
- No. of Employees
- 60
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
London Stock Exchange
- Shares in Issue
- 31,170,093

- Address
- Tunbridge Court, CAMBRIDGE, CB25 9TU
- Web
- http://www.cambridgecognition.com/
- Phone
- Auditors
- Grant Thornton UK LLP
Latest News for COG
Upcoming Events for COG
Half Year 2022 Cambridge Cognition Holdings PLC Earnings Release
Similar to COG
1Spatial
London Stock Exchange
4Global
London Stock Exchange
Access Intelligence
London Stock Exchange
accesso Technology
London Stock Exchange
Activeops
London Stock Exchange
FAQ
As of Today at 13:04 UTC, shares in Cambridge Cognition Holdings are trading at 117.50p. This share price information is delayed by 15 minutes.
Shares in Cambridge Cognition Holdings last closed at 117.50p and the price had moved by -17.54% over the past 365 days. In terms of relative price strength the Cambridge Cognition Holdings share price has underperformed the FTSE All Share Index by -15.57% over the past year.
The overall consensus recommendation for Cambridge Cognition Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Cambridge Cognition Holdings does not currently pay a dividend.
Cambridge Cognition Holdings does not currently pay a dividend.
Cambridge Cognition Holdings does not currently pay a dividend.
To buy shares in Cambridge Cognition Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 117.50p, shares in Cambridge Cognition Holdings had a market capitalisation of £36.62m.
Here are the trading details for Cambridge Cognition Holdings:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: COG
Based on an overall assessment of its quality, value and momentum Cambridge Cognition Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Cambridge Cognition Holdings is 197.33p. That is 67.94% above the last closing price of 117.50p.
Analysts covering Cambridge Cognition Holdings currently have a consensus Earnings Per Share (EPS) forecast of £0.02 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cambridge Cognition Holdings. Over the past six months, its share price has underperformed the FTSE All Share Index by -0.92%.
As of the last closing price of 117.50p, shares in Cambridge Cognition Holdings were trading -13.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cambridge Cognition Holdings PE ratio based on its reported earnings over the past 12 months is 60.74. The shares last closed at 117.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Cambridge Cognition Holdings' management team is headed by:
- Steven Powell - NEC
- Matthew Stork - CEO
- Michael Holton - EDR
- Richard Bungay - NID
- Debra Leeves - NID